Radha Sharma

Radha Sharma

Auto-generated profile, based on publicly available information

Radha Sharma

RUHS CMS, Jajpur, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in JMIR AI
Verified
Journal Article
Open access
TOTanvi Ojha
Tanvi Ojha
APAtushi Patel
Atushi Patel
KSKrishihan Sivapragasam
Krishihan Sivapragasam
RSRadha Sharma
Radha Sharma
TVTina Vosoughi
Tina Vosoughi
BHBanafshe Benita Hosseini
Banafshe Benita Hosseini
Background: The integration of machine learning (ML) in predicting asthma-related outcomes in children presents a novel approach in pediatric health care. Objective: This scoping review aims to analyze studies published since 2019, focusing on ML algorithms, their applications, and predictive performances. Methods: We searched Ovid MEDLINE ALL and Embase on Ovid, the Cochrane Library (Wiley), CINAHL (EBSCO), and Web of Science (core collection). The search covered the period from January 1, 2019, to July 18, 2023. Studies applying ML models in predicting asthma-related outcomes in children aged <18 years were included. Covidence was used for citation management, and the risk of bias was assessed using the Prediction Model Risk of Bias Assessment Tool. Results: From 1231 initial articles, 15 met our inclusion criteria. The sample size ranged from 74 to 87,413 patients. Most studies used multiple ML techniques, with logistic regression (n=7, 47%) and random forests (n=6, 40%) being the most common. Key outcomes included predicting asthma exacerbations, classifying asthma phenotypes, predicting asthma diagnoses, and identifying potential risk factors. For predicting exacerbations, recurrent neural networks and XGBoost showed high performance, with XGBoost achieving an area under the receiver operating characteristic curve (AUROC) of 0.76. In classifying asthma phenotypes, support vector machines were highly effective, achieving an AUROC of 0.79. For diagnosis prediction, artificial neural networks outperformed logistic regression, with an AUROC of 0.63. To identify risk factors focused on symptom severity and lung function, random forests achieved an AUROC of 0.88. Sound-based studies distinguished wheezing from nonwheezing and asthmatic from normal coughs. The risk of bias assessment revealed that most studies (n=8, 53%) exhibited low to moderate risk, ensuring a reasonable level of confidence in the findings. Common limitations across studies included data quality issues, sample size constraints, and interpretability concerns. Conclusions: This review highlights the diverse application of ML in predicting pediatric asthma outcomes, with each model offering unique strengths and challenges. Future research should address data quality, increase sample sizes, and enhance model interpretability to optimize ML utility in clinical settings for pediatric asthma management.

1 July 2018 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
NNNeeraj Nagaich
Neeraj Nagaich
RSRadha Sharma
Radha Sharma
SNSubhash Nepalia
Subhash Nepalia

1 July 2018 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
PDF file
NNNeeraj Nagaich
Neeraj Nagaich
RSRadha Sharma
Radha Sharma
SNSubhash Nepalia
Subhash Nepalia

1 March 2024 in JMIR Preprints
Verified
Preprint
Open access
TOTanvi Ojha
Tanvi Ojha
APAtushi Patel
Atushi Patel
KSKrishihan Sivapragasam
Krishihan Sivapragasam
RSRadha Sharma
Radha Sharma
TVTina Vosoughi
Tina Vosoughi
BHBanafshe Benita Hosseini
Banafshe Benita Hosseini
BACKGROUND The integration of machine learning (ML) in predicting asthma-related outcomes in children presents a novel approach in pediatric health care. OBJECTIVE This scoping review aims to analyze studies published since 2019, focusing on ML algorithms, their applications, and predictive performances. METHODS We searched Ovid MEDLINE ALL and Embase on Ovid, the Cochrane Library (Wiley), CINAHL (EBSCO), and Web of Science (core collection). The search covered the period from January 1, 2019, to July 18, 2023. Studies applying ML models in predicting asthma-related outcomes in children aged <18 years were included. Covidence was used for citation management, and the risk of bias was assessed using the Prediction Model Risk of Bias Assessment Tool. RESULTS From 1231 initial articles, 15 met our inclusion criteria. The sample size ranged from 74 to 87,413 patients. Most studies used multiple ML techniques, with logistic regression (n=7, 47%) and random forests (n=6, 40%) being the most common. Key outcomes included predicting asthma exacerbations, classifying asthma phenotypes, predicting asthma diagnoses, and identifying potential risk factors. For predicting exacerbations, recurrent neural networks and XGBoost showed high performance, with XGBoost achieving an area under the receiver operating characteristic curve (AUROC) of 0.76. In classifying asthma phenotypes, support vector machines were highly effective, achieving an AUROC of 0.79. For diagnosis prediction, artificial neural networks outperformed logistic regression, with an AUROC of 0.63. To identify risk factors focused on symptom severity and lung function, random forests achieved an AUROC of 0.88. Sound-based studies distinguished wheezing from nonwheezing and asthmatic from normal coughs. The risk of bias assessment revealed that most studies (n=8, 53%) exhibited low to moderate risk, ensuring a reasonable level of confidence in the findings. Common limitations across studies included data quality issues, sample size constraints, and interpretability concerns. CONCLUSIONS This review highlights the diverse application of ML in predicting pediatric asthma outcomes, with each model offering unique strengths and challenges. Future research should address data quality, increase sample sizes, and enhance model interpretability to optimize ML utility in clinical settings for pediatric asthma management. CLINICALTRIAL